Public Health Agency of Canada / Agence de santé publique du Canada
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m Skip all navigation -accesskey z
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
    Public Health Agency of Canada (PHAC)
Tuberculosis FACT SHEET
   
  BCG
  Contact tracing
  Drug-Resistant TB
  Infectious TB disease
  Taking TB drugs
  TB and HIV infection
  TB disease outside the lungs
  TB disease
  TB infection
  TB skin test
  TB transmission
  TB infection progressing to TB disease
  Treatment of TB disease
  Treatment of TB infection
  What is TB?
  Who is at risk for TB in Canada?
 

BCG

What is BCG?

 BCG (Bacille Calmette-Guérin) is a live vaccine that was developed by two French scientists Calmette and Guérin in the 1920s. It helps protect babies and young children against the most severe forms of TB disease. BCG is one of the most common vaccines in the world. It is frequently used in other countries where TB infection and TB disease are more common.

In Canada, children in Newfoundland and Quebec received BCG routinely until the 1980s. Today, only some First Nations children on reserves receive BCG routinely. People vaccinated with BCG may have a positive reaction to a TB skin test. This reaction may be due to the BCG vaccine or to a real TB infection. The reaction from BCG fades over time, and adults who were vaccinated as children should consider a positive skin test as true TB infection. Adults who had many BCG vaccinations, or who were vaccinated after the age of 6 years, may have a positive TB skin test because of BCG. However, it is safest to have further testing to rule out TB disease.

PDF Version PDF

[Tuberculosis FACT SHEET - Index]


Last Updated: 2004-06-22 Top